UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (50) 50
humans (49) 49
life sciences & biomedicine (47) 47
oncology (38) 38
female (36) 36
male (36) 36
middle aged (36) 36
aged (32) 32
adult (21) 21
lung neoplasms - pathology (20) 20
biological and medical sciences (19) 19
medical sciences (19) 19
lung cancer (18) 18
lung neoplasms - drug therapy (17) 17
respiratory system (16) 16
carcinoma, non-small-cell lung - drug therapy (15) 15
pneumology (14) 14
neoplasm staging (13) 13
tumors of the respiratory system and mediastinum (13) 13
carcinoma, non-small-cell lung - pathology (11) 11
treatment outcome (11) 11
tumors (11) 11
lung cancer, non-small cell (10) 10
prognosis (10) 10
abridged index medicus (9) 9
aged, 80 and over (9) 9
mesothelioma - pathology (9) 9
prospective studies (9) 9
radiology, nuclear medicine & medical imaging (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
care and treatment (8) 8
lung neoplasms - genetics (8) 8
cancer (7) 7
carcinoma, non-small-cell lung - genetics (7) 7
hematology, oncology and palliative medicine (7) 7
pleural neoplasms - pathology (7) 7
surgery (7) 7
chemotherapy (6) 6
immunotherapy (6) 6
lung neoplasms - diagnostic imaging (6) 6
lung neoplasms - metabolism (6) 6
lung neoplasms - mortality (6) 6
non-small cell lung cancer (6) 6
research (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carcinoma, non-small-cell lung - diagnostic imaging (5) 5
carcinoma, non-small-cell lung - radiotherapy (5) 5
combined modality therapy (5) 5
deoxycytidine - analogs & derivatives (5) 5
disease-free survival (5) 5
dosage and administration (5) 5
lung neoplasms - radiotherapy (5) 5
lung neoplasms - surgery (5) 5
medicine & public health (5) 5
mesothelioma (5) 5
metastasis (5) 5
pulmonary/respiratory (5) 5
radiotherapy (5) 5
sensitivity and specificity (5) 5
survival rate (5) 5
antineoplastic agents (4) 4
antineoplastic agents - therapeutic use (4) 4
cisplatin - administration & dosage (4) 4
deoxycytidine - administration & dosage (4) 4
diagnosis (4) 4
disease progression (4) 4
fluorodeoxyglucose f18 (4) 4
gemcitabine (4) 4
general & internal medicine (4) 4
malignant pleural mesothelioma (4) 4
mesothelioma - diagnosis (4) 4
mesothelioma - drug therapy (4) 4
mesothelioma, malignant (4) 4
neoadjuvant therapy (4) 4
patients (4) 4
pleural neoplasms - diagnosis (4) 4
pleural neoplasms - drug therapy (4) 4
retrospective studies (4) 4
time factors (4) 4
tomography, x-ray computed (4) 4
analysis (3) 3
animals (3) 3
cancer research (3) 3
carboplatin - administration & dosage (3) 3
carcinoma, non-small-cell lung - metabolism (3) 3
cisplatin (3) 3
critical care medicine (3) 3
ct imaging (3) 3
follow-up studies (3) 3
lung neoplasms (3) 3
lung neoplasms - complications (3) 3
lung neoplasms - secondary (3) 3
lungs (3) 3
mesothelioma - epidemiology (3) 3
mesothelioma - metabolism (3) 3
methods (3) 3
mutation (3) 3
neoplasm recurrence, local (3) 3
neoplasm staging - methods (3) 3
non-small cell lung carcinoma (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 07/2018, Volume 19, Issue 7, pp. 853 - 855
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
Investigational new drugs, ISSN 0167-6997, 2015, Volume 33, Issue 1, pp. 201 - 214
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Respirology (Carlton, Vic.), ISSN 1323-7799, 05/2015, Volume 20, Issue 4, pp. 521 - 521
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2038 - 2045
RHEUMATOID-ARTHRITIS | TRIAL | POLYMORPHISMS | CISPLATIN | METHYLENETETRAHYDROFOLATE REDUCTASE GENE | 2ND-LINE TREATMENT | METHOTREXATE | DOCETAXEL | UMCG Approved | THYMIDYLATE-SYNTHASE | CHEMOTHERAPY | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Guanine - analogs & derivatives | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Membrane Transport Proteins - genetics | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | gamma-Glutamyl Hydrolase - genetics | Lung Neoplasms - genetics | Pharmacogenetics | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Carboplatin - administration & dosage | Survival Rate | Treatment Outcome | Adenocarcinoma - drug therapy | Pemetrexed | Thymidylate Synthase - genetics | Adenocarcinoma - secondary | Disease Progression | Reduced Folate Carrier Protein | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Glutamates - administration & dosage | Carcinoma, Squamous Cell - secondary | Polymorphism, Genetic - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Guanine - administration & dosage | Index Medicus
Journal Article
Journal Article